India, Aug. 5 -- Scientists at Tel Aviv University suggested that the erectile dysfunction drug sildenafil, sold as Viagra, may help stop cancer from spreading to other parts of the body.
The study, involving researchers from the U.S. National Cancer Institute, Clalit Health Services, and Rabin Medical Center in Israel, found that the drug appears to reduce cancer cells' ability to use cholesterol, which they need to spread to other organs.
The findings were based on experiments in mice, cancer cells taken from human patients, and 20 years of medical records from about 5 million members of Clalit Health Services. The researchers found that cancer patients who used sildenafil had better survival rates, especially those who also took statin...